PCCs for PharmD Part II

1

Introduction

00:00 • 3min

2

What's the Deal With Colorado?

02:32 • 4min

3

Dosing Protocols for Tenna Inhibitors?

06:55 • 3min

4

Fixed Dosing Protocols

09:43 • 2min

5

Anticoagulation Reversal - Is There a Difference in Time to Administration?

11:43 • 3min

6

Is There Any Research Comparing Three Pact Factor Pc C With Four Pact C?

14:49 • 3min

7

Is There Any Data Comparing Our Four Factor Agents?

17:59 • 4min

8

Do You Need to Increase the Dose of Peba?

21:49 • 4min

9

The Biggest Pharmacist Study Ever

26:05 • 3min

10

Aarand Cook and Morgan Jones, Both Friends of the Pod

29:33 • 3min

11

Is There Any Evidence for Non-Reversal Indications?

32:43 • 4min

12

I'm Hearing Four Packs of Platelets in the O R

36:28 • 4min

13

Is There Any Evidence for the Use of Pc C's Verse and Dexa in Coagulation?

40:01 • 3min

14

Is It a Panosis Study?

43:25 • 2min

15

I'll Believe the Smaller Ones When They Match the Big Ones

45:39 • 2min

16

Hematoma Expansion Among Pc C Patients

47:24 • 2min

17

Do You Know What Happens if You Get Both?

49:48 • 4min

18

Is There a Guideline on the Use of PCC or Indexina Alpha?

53:21 • 5min

19

Reversal of Tennin Inhibitors

58:33 • 3min

20

Tramadol - Is There a Study on the Horizon?

01:01:33 • 2min

21

The Dosing Is Higher Than We've Ever Seen Before

01:03:20 • 2min

22

Then I'll Be on the Lookout for the Results

01:05:46 • 2min

23

I'll Give the Deck to Everybody, if There's a Red Wedding

01:08:04 • 5min